Feeds › Patents
Patents
New US patents granted to public companies.
About this data
- What it is
- The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
- Who files it
- The USPTO publishes each grant.
- How current
- Grants are published every Tuesday, and we collect them weekly.
- Worth knowing
- A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Patents granted per week, last 12 weeks
Latest patent grants
Showing: ticker ALLO
| Granted | Patent | Owner | Type | Source |
|---|---|---|---|---|
| Nov 10, 2026 | 12790603 Modified caspase-9 polypeptides and methods of use thereof | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Apr 21, 2026 | 12606623 DLL3 targeting chimeric antigen receptors and binding agents | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Mar 24, 2026 | 12583905 Methods and compositions for dosing of allogeneic chimeric antigen re… | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Mar 17, 2026 | 12577290 FasL expression and FasR gene knockout to protect therapeutic cells f… | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Mar 17, 2026 | 12577283 Knockdown or knockout of one or more of TAP2, NLRC5, B2m, TRAC, RFX5,… | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Jan 20, 2026 | 12528856 Chimeric cytokine receptors comprising TGF β binding domains | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Oct 21, 2025 | 12447178 Method of treatment using anti-CD19 rituximab-resistant chimeric anti… | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Sep 2, 2025 | 12404315 Protease-activating CD45-gate CAR | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Jul 22, 2025 | 12365873 Methods for transducing immune cells | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| May 13, 2025 | 12295362 Formulations and processes for CAR T cell drug products | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Feb 11, 2025 | 12221462 Methods and compositions for dosing of allogeneic chimeric antigen re… | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Feb 4, 2025 | 12215347 Chimeric antigen receptors with enhanced signaling and activities and… | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Dec 10, 2024 | 12163169 Inducible chimeric cytokine receptors | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
| Dec 10, 2024 | 12163153 Methods of manufacturing allogeneic CAR T cells | ALLO Allogene Therapeutics, Inc. | utility | Google Patents ↗ |
14 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:58 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances